Structure Therapeutics Inc - American Depositary Shares — Cash Flow (NASDAQ:GPCR) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics

Quarterly Annual

Cash from operating activities -79.49 M-116.64 M-222.2 M -222.2 M Cash from investing activities -268.34 M-358.91 M89.8 M 89.8 M Cash from financing activities 451.53 M515.26 M762.52 M 762.52 M Free cash flow -81.66 M-117.93 M-225.81 M -225.81 M

Haberler

Structure Therapeutics, Matthew Lang’ı COO ve hukuk müşaviri seçti

Does NVO Face Rising Competitive Pressure on LLY's Foundayo Approval?

Structure Therapeutics: The Oral Obesity Inflection, Best-In-Class Efficacy

Structure Therapeutics: A High-Risk, High-Reward Bet On The Next GLP-1 Blockbuster (GPCR)

Wolfe Research, Structure Therapeutics hissesine Peerperform notu verdi

NVO vs. GPCR: Which Obesity Stock is the Better Buy Right Now?

Eli Lilly's Experimental Drug Retatrutide Delivers Strong Weight Loss In Late-Stage Trial

Why Did Eli Lilly Stock Slide 6% Despite Strong GLP-1 Momentum?

BMO raises Structure Therapeutics stock price target on obesity drug data

Structure Therapeutics' GLP-1 Agonist Could Be A Potential Acquisition Target (GPCR)

H.C. Wainwright, Structure Therapeutics için hedef fiyatı düşürdü

H.C. Wainwright lowers Structure Therapeutics price target on penetration assumptions